Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Sulfasalazine-induced agranulocytosis is associated with the human leukocyte antigen locus
- In: Short Communications E1 on Monday, 22 May 2017, 13:30-15:00
- At: Stockholm (Sweden) (2017)
- Type: Presentation
- By: WADELIUS, Mia (Uppsala University, Medical Sciences, Clinical Pharmacology, Uppsala, Sweden)
- Co-author(s): Mia Wadelius: Department of Medical Sciences and Science for Life Laboratory, Uppsala University, Uppsala , Sweden
Niclas Eriksson: Medical Sciences, Uppsala University, Uppsala, Sweden;Uppsala Clinical Research Center, Uppsala Region, Uppsala, Sweden
Reinhold Kreutz: Charité - Universitätsmedizin Berlin, Institut für Klinische Pharmakologie und Toxikologie, Berlin, Germany
Emmanuelle Bondon-Guitton: Service de Pharmacologie Médicale et Clinique, Faculté de Médecine de l'Université de Toulouse, Toulouse, France
Luisa Ibañez: Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
Alfonso Carvajal: Centro de Estudios sobre la Seguridad de los Medicamentos, Universidad de Valladolid, Valladolid, Spain
M. Isabel Lucena: Instituto de Investigación Biomédica de Málaga, University of Málaga, Málaga, Spain
Esther Sancho Ponce: Servei d'Hematologia i Banc de Sang, Hospital General de Catalunya, Sant Cugat del Vallès, Spain
Mariam Molokhia: NIHR Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation, King's College London, London, United Kingdom
Javier Martin: Instituto de Parasitologia y Biomedicina Lopez-Neyra, CSIC, Granada, Spain
Tomas Axelsson: Department of Medical Sciences and Science for Life Laboratory, Uppsala University, Uppsala , Sweden
Hugo Kohnke: Department of Medical Sciences and Science for Life Laboratory, Uppsala University, Uppsala , Sweden
Qun-Ying Yue: Medical Products Agency, Swedish State Authority, Uppsala, Sweden
Patrik K. E. Magnusson: Swedish Twin Registry, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Mats Bengtsson: Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
Pär Hallberg: Department of Medical Sciences and Science for Life Laboratory, Uppsala University, Uppsala , Sweden - Abstract:
Backgrounds
Agranulocytosis is a serious rare adverse reaction to sulfasalazine, which is used to treat inflammatory joint and bowel disease. The reaction is believed to be immune-mediated, but risk factors are unknown.
Aims
The European Drug-induced Agranulocytosis Consortium (EUDAC) aimed to find genetic risk factors for
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023